Sun Pharma Advanced Research Company Ltd (Sparc) said it was reducing its overall workforce by 40 per cent, largely in the US. The projected number of people in the company is 246 by FY27, down from ...

Commonwealth Fusion Systems said Tuesday at CES 2026 that it has installed the first superconducting magnet for its Sparc fusion reactor, a key milestone for the experimental system the company aims ...

US fusion firm Commonwealth Fusion Systems (CFS) has announced partnerships with Nvidia and Siemens to develop a digital twin of its SPARC fusion reactor. The companies claim they will apply ...

Billionaire investor Bill Ackman on Saturday proposed merging SpaceX with Pershing Square SPARC Holdings, a special purpose acquisition rights vehicle created by his firm, Pershing Square Capital ...

Billionaire investor Bill Ackman pitched an innovative approach to taking SpaceX (SPACE) public through a merger with Pershing Square SPARC Holdings. Ackman's plan would distribute special purpose ...

Keeping their uptrend intact for the second session, shares of Sun Pharma Advanced Research Company (SPARC) soared another 11.5% in Wednesday’s session, December 3, hitting a six-month high of ₹179.50 ...

The shares of Sun Pharma Advanced Research Company (SPARC) jumped 20 percent on December 2. This comes after a US district court passed an order in favour of the company for its 'Sezaby' injection.

A key component of a system that would deliver fusion energy in the U.S. has arrived at Commonwealth Fusion Systems’ (CFS) campus in Devens, Massachusetts. The company on October 28 said the first ...

In total, SPARC has approved approximately 800 joint proposals across its two phases. The Ministry of Education has relaunched the online portal for its flagship Scheme for Promotion of Academic and ...

A team of experts in the U.S. has successfully used a technique called step-and-shoot spot-scanning proton arc therapy (SPArc) to treat a patient’s adenoid cystic carcinoma for the first time. SPArc ...

SPARC share price: Shares of Sun Pharma Advanced Research Company (SPARC), the research division of India’s top pharmaceutical firm Sun Pharma, fell 20% on Wednesday after unsatisfactory results from ...